@TOTALDESTRUCTION Tc,
Not sure where your getting your info from. Orphan Drug status by Fda will be approved after another 23 patients for Hypoglycemic diabetics. That will be less than 2 years imo .... not Type 1 Diabetes... that will take a few years with multicenter study and much larger patient pool.
They also have indications for Hemophilia and Thyroid and possibly a few others not mentioned yet.
There were 3 sets of warrants to be exercised . They will be done by end of the week. Weak hands are gone, some longterm shareholders from 5 cent placement cashed out . You can't blame them for waiting more than 10 years.
It's going to take a pharma collaboration that involves equity stake and this will be a double from here. Conparabkes are valued at $1 Billion US with no clinical Fda trials .
it does not matter what you say Totalcorruption because the share price will be determined by the market .... will be at much higher valuations.
Just hope you did not short it .
Elgin